Autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and lupus are tough to treat. Current treatments just calm down the immune system's attack on the body, but they don't fix the root cause. This means patients often face a lifetime of expensive medications, injections, or infusions w
CAR-T therapy, a cutting-edge cancer treatment, can sometimes lead to a condition called ICANS. This condition can cause seizures, and doctors have been studying brain wave patterns to better understand it. Doctors have been looking at continuous EEG data from patients with ICANS. They want to see
In the fight against cancer, scientists are always looking for new ways to make treatments work better. One big challenge is that cancer cells can become resistant to drugs over time. To tackle this, researchers have come up with a clever idea: combining two powerful tools to attack cancer cells fro
DLBCL is a type of blood cancer that can be tough to treat. It stands for diffuse large B-cell lymphoma. The introduction of CAR-T therapy has been a game-changer for patients with relapsed or refractory DLBCL. CAR-T therapy is a type of treatment that uses a patient's own immune cells to fight ca
Multiple myeloma (MM) is a type of cancer that affects plasma cells. It can be treated with CAR-T cell therapy, which uses engineered T cells to target and kill cancer cells. However, relapse can happen. The relapse can occur even after a long period of remission. This is a big problem. It can happe
At a single hospital, patients with large B-cell lymphoma (LBCL) who didn't respond to initial treatments were given either lisocabtagene maraleucel (liso-cel) or axicabtagene ciloleucel (axi-cel). Liso-cel is newer and not widely studied outside clinical trials yet. From June 2021 to September 2022
